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Abstract
Although the pathology of Morbillivirus in the central nervous system (CNS) is well described, the molecular basis of
neurodegenerative events still remains poorly understood. As a model to explore Morbillivirus-mediated CNS dysfunctions,
we used canine distemper virus (CDV) that we inoculated into two different cell systems: a monkey cell line (Vero) and rat
primary hippocampal neurons. Importantly, the recombinant CDV used in these studies not only efficiently infects both cell
types but recapitulates the uncommon, non-cytolytic cell-to-cell spread mediated by virulent CDVs in brain of dogs. Here,
we demonstrated that both CDV surface glycoproteins (F and H) markedly accumulated in the endoplasmic reticulum (ER).
This accumulation triggered an ER stress, characterized by increased expression of the ER resident chaperon calnexin and
the proapoptotic transcription factor CHOP/GADD 153. The expression of calreticulin (CRT), another ER resident chaperon
critically involved in the response to misfolded proteins and in Ca2+ homeostasis, was also upregulated. Transient
expression of recombinant CDV F and H surface glycoproteins in Vero cells and primary hippocampal neurons further
confirmed a correlation between their accumulation in the ER, CRT upregulation, ER stress and disruption of ER Ca2+
homeostasis. Furthermore, CDV infection induced CRT fragmentation with re-localisation of a CRT amino-terminal fragment,
also known as vasostatin, on the surface of infected and neighbouring non-infected cells. Altogether, these results suggest
that ER stress, CRT fragmentation and re-localization on the cell surface may contribute to cytotoxic effects and ensuing cell
dysfunctions triggered by Morbillivirus, a mechanism that might potentially be relevant for other neurotropic viruses.
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Introduction
Canine distemper virus (CDV), closely related to measles virus
(MV), belongs to the Morbillivirus genus of the Paramyxoviridae
family. The CDV genome consists of a non-segmented, single-
stranded RNA molecule of negative polarity. Both CDV and the
human pathogen MV may induce dramatic complications in the
central nervous system (CNS). Due to similarities between CDV-
mediated demyelination and human multiple sclerosis (MS), the
canine disease represents one of the few spontaneously occurring
animal models to study the pathogenesis of myelin loss associated
with infectious and immune-mediated mechanisms [1]. Epidemi-
ological observations strongly suggest that MS is a disease caused
by an infectious agent that induces an immune-mediated
demyelinating disease. While much progress has been made in
recent years, the pathogenesis of MS is still unclear, and animal
models of viral demyelination remain important tools in MS
research. Common to most animal models of viral demyelination
is viral persistence, the driving force behind the progression of the
disease. Thus, understanding the mechanisms of viral persistence
might contribute to our understanding of chronic demyelinating
diseases. For these reasons, CDV is considered as a model for
human multiple sclerosis, as well as for the study of Morbillivirus-
mediated pathogenesis [1,2].
We previously found that a recombinant CDV (rgA75/17-V),
closely related to the wild-type neurovirulent A75/17 strain, could
infect neuron and astrocyte primary cultures from the rat brain,
inducing a persistent, non-cytolytic infection. Using this model, we
demonstrated that, following CDV infection, glutamate release in
the extra-cellular compartment was involved in the induction of
neuronal cell death in infected and neighbouring non-infected cells
[3].
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ER stress is caused by conditions that perturb ER functions
including calcium release and accumulation of misfolded protein
[4,5]. When misfolded proteins accumulate in the ER, a
stereotypical cellular program called the unfolded protein response
is activated, which allows the cell to restore physiological
conditions [4,5]. Initially the cell reacts by expressing more
chaperons, such as calreticulin (CRT), but, under persistent stress
such as observed in viral infection, the unfolded protein response
switches from being pro-survival to proapoptotic [5,6]. At this
stage, the cell starts to transcribe proapoptotic transcription factors
such as the growth arrest- and DNA damage-inducible gene 153
(CHOP/GADD 153) [7,8].
In attempts to characterize the mechanisms of ER stress that
might be induced by CDV infection, we focused our attention on
the 60-kDa molecular chaperon CRT. This protein has been
shown to modulate the homeostasis of calcium (Ca2+) in the cell
[9]. We demonstrated that in Vero cells and primary hippocampal
neurons the CDV surface glycoproteins markedly accumulated in
the ER. This was correlated with a strong upregulation of the
molecular chaperons CRT and calnexin, two ER stress-dependent
proteins. Over-expression of the proapoptotic transcription factor
CHOP/GADD 153 was also demonstrated. Importantly, ER
stress and CRT over-expression were closely associated with
increase in cytosolic Ca2+. Finally, in an unanticipated manner, we
detected the 27-kDa N-terminal CRT cleavage product, also
termed vasostatin, in CDV infected cells. Remarkably, we
demonstrated the presence of CRT N-terminal fragments at the
cell surface of both infected and neighbouring non-infected cells,
an event that may contribute to the CDV and other virus-
mediated neurodegeneration.
Materials and Methods
Viruses and plasmids
The previously reported recombinant A75/17-V virus contains
an additional transcription unit coding for the enhanced green
fluorescent protein (e-GFP) in the 39 proximal position in the
genome, generating rgA75/17-V [10]. To simplify the nomencla-
ture we named the recombinant Vero-cells adapted rgA75/17-V
as ‘‘CDV’’.
Construction of expression plasmids: The plasmids pF-CDV,
pF-CDV-ER, pH-CDV and pN-CDV were described previously
[10,11]. After expression, the CDV proteins are named F CDV, F-
ER CDV, H CDV and N CDV proteins, respectively. The
constructs were made in the mammalian expression vector pCI
(Promega, Madison, USA) using PCR and recombinant PCR
techniques (Pfu Turbo DNA polymerase, Stratagene-Agilent,
Santa Clara, USA). All plasmid sequences were confirmed by
automated nucleotide sequence analysis.
Cell culture, infection, and transfection
Vero cells (ATCC, CCL-81) were grown in Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma, St. Louis, USA)
supplemented with 10% fetal calf serum (FCS), penicillin, and
streptomycin (Gibco, invitrogen group, Carlsbad, USA) and all the
cultures were incubated at 37uC in a humidified atmosphere
containing 5% CO2, as previously described [10]. Hippocampal
rat brain cells were prepared from new born rats [12] and were
approved (No. 1150.4) by the cantonal regulation of animal care.
Hippocampi without dentate gyri were dissociated with papain
and triturated using a glass pipette. After centrifugation at 400 g
for 2 minutes, cells were plated on individual wells (35 mm) of 6-
well plates, each containing poly-D-lysin/laminin-coated borosil-
icate coverslips (15 mm diameter) at a density of 250000 cells/dish
in DMEM 10% FCS. The medium was changed after 3 h to a
Neurobasal/B27 medium (Invitrogen, Carlsbad, USA).
One day after seeding, Vero cell cultures at 90% of confluence
were infected with CDV at the multiplicity of infections (MOI) of
0.03. Hippocampal rat brain cells were infected with CDV two
days after seeding at a MOI of 0.003. Transfection were
performed one day after seeding using Lipofectamin (Invitrogen,
Carlsbad, USA) (1 mg of each plasmid as indicated in the figure
legends, in 2 ml Lipofectamine 2000TM) for a period of 24 hrs.
Transfections were performed in 35 mm dishes. For calcium signal
analyses, Vero cells and hippocampal rat brain cells were
transfected transiently for a period of 24 hours with Lipofectamin
2000TM (Invitrogen, Carlsbad, USA) (1 mg DNA per 2,5 mL of
Lipofectamin 2000TM for Vero cells and 1,8 mg DNA per 3,3 mL
of Lipofectamin 2000TM for hippocampal rat brain cells) in a 35-
mm dish. Transfection was done for 2 hours at 37uC, 5% CO2
and all plasmids were transfected in equal quantities.
Immunofluorescence staining
The following mouse monoclonal antibodies were used: anti-
calreticulin (CRT) C-terminal domain (CRT-C-term) (Becton and
Dickinson BD Bioscience, Erembodegem, Belgium), anti-calnexin
(Abcam, Cambridge, UK), anti-C/EBP-homologous protein
(CHOP/GADD 153) (Santa Cruz Biotechnology, Santa Cruz,
USA), anti-CDV nucleoprotein (D110) [13], anti-Flag and anti-
HA (Sigma, St. Louis, USA), anti-GAPDH (cell Signalling,
Danvers, USA), anti-hrp, (Sigma, St. Louis, USA). Also were
used rabbit polyclonal sera against CDV F and H proteins [11],
anti-CRT N-terminal domain (CRT-N-term, kindly provided by
Dr. Daniel Law University of Geneva [14], anti-Flag (Sigma, St.
Louis, USA), anti-HA (Sigma, St. Louis, USA), anti-wheat germ
agglutinin (WGA) Alexa 405 conjugated (Invitrogen, Carlsbad,
USA), and anti-hrp, (Sigma, St. Louis, USA). The secondary
antibodies were FITC- (Sigma, St. Louis, USA), CY3- (Chemicon,
Temecula, USA), CY5- (Jackson ImmunoResearch Laboratories,
Suffolk, UK) or Alexa 594 (Invitrogen, Carlsbad, USA) conjugated
antibodies.
For CRT C-terminal immunofluorescence, infected or trans-
fected cell cultures were fixed in 100% methanol for 10 minutes at
220uC. The fixed cultures were washed in a phosphate saline
buffer (PBS). Cultures were blocked in a blocking solution (5%
normal goat serum in PBS 1%) for 10 minutes, followed by
staining with the CRT-C-terminal antibody. For all the other
antibodies and antisera, cultures were fixed in 4% paraformalde-
hyde for 20 min at 4uC. Cells were then permeabilized (0.1%
Triton X100 in PBS) for 10 minutes and blocked in a blocking
solution (5% normal goat serum in PBS) for 1 hour, followed by
staining with the different antibodies. Incubation with the various
antibodies and antisera was performed overnight at 4uC. All
antibodies were diluted in a blocking solution. The secondary
antibody was added for 1 hour at RT. After intensive washing, cell
nuclei were stained with 496-diamidino-2-phenylindole (DAPI,
Sigma, St. Louis, USA) and subsequently examined by Laser
Scanning Confocal microscopy. All images were taken with a Zeiss
LSM 510 Meta confocal microscope, the Zeiss LSM 510 confocal
scan head was coupled with an Axiovert 200 M microscope (Carl
Zeiss, Jena, Germany).
Calcium signal analyses
To follow Ca2+ signals, GFP-aequorin (GA) was used. GA is a
fusion protein between aequorin and GFP, which emits lumines-
cent signals when it binds 3 Ca2+ ions. This requires the presence
of coelenterazine for the intracellular regeneration of the
photoprotein [15]. When Ca2+ binds to the aequorin protein, it
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undergoes a conformation change that results in the oxidation of
coelenterazine and the emission of a single photon. In the jellyfish,
binding of Ca2+ to aequorin results in an intermolecular non-
radiative energy transfer to GFP. This process is known as
chemiluminescence resonance energy transfer (CRET). In our
case, GFP and aequorin were fused genetically and an
intramolecular transfer of Ca2+ activated aequorin luminescence
energy to GFP occurred, resulting in the emission of a green light
[16,17]. GA is therefore a bi-functional reporter, whereby
expression patterns can be monitored by GFP fluorescence, while
Ca2+ activities can be measured by GFP fluorescence with single-
cell resolution.
GA expression was obtained via transfection of the correspond-
ing recombinant plasmid. Coelenterazine (Interchim, Montluc¸on,
France) is membrane permeable and was added to the transfected
cells at 5 mM, for pre-incubation at 37uC for 60 min in a tyrode
buffer containing Ca2+. In Vero cells, Ca2+ signals were then
recorded in phenol red-free DMEM, L-glutamine (2 mM), FCS
10%, Hepes (20 mM) medium while hippocampal rat brain cells
were recorded in a medium containing NaCl (128 mM), KCl
(5 mM), CaCl2 (2,7 mM), glucose (10 mM), Hepes (20 mM),
MgCl2 (1 mM), pH 7,4.
The calibration of photon data was carried out as follows. Light
emission is expressed as the fractional rate of photoprotein
consumption, which is the ratio between the emission of Light (L,
minutes) from that time point and the integral of total light emission
from that point until full exhaustion of the photoprotein (Lmax).
Photons were counted over 60 seconds every 10 minutes during
24 hours, by using a photon counting system (ACTIMETRICS,
Wilmette, IL). After 17 hours of recording in Vero cell cultures, or
21 hours for the hippocampal rat brain cells, ionomycin (2 mM)
was added to release all Ca2+ from ER stores and from the cells. A
high CaCl2 solution (10 mM) was then added in order to quantify
the total amount of photoprotein (Lmax). Each sample was analysed
in triplicate in three separate experiments.
Western Blot
48 hours after infection, Vero cells were washed in PBS at 4uC,
then exposed to a lysis buffer (M-PER Mammalian Protein
Extraction Reagent, PIERCE-Perbio bioscience, Alost, Belgium)
supplemented with protease inhibitors (Halt Protease Inhibitor
Cocktail, EDTA-Free, PIERCE-Perbio bioscience, Alost, Bel-
gium). Cell lysates were scraped off culture dishes and centrifuged
(14000 g; 10 minutes at 4uC) to recover cytosolic proteins in the
supernatant. Proteins were quantified using nanodrop. The
samples were diluted in adequate volumes of standard denaturat-
ing buffer. Protein (25 mg/lane) were separated by sodium
dodecylsulfate-polyacrilamide gel electrophoresis (SDS-PAGE) at
120 V for 1 hour and 30 minutes on 12% acrylamide gels, and
subsequently transferred to PVDF membranes (Westran Mem-
brane, Schleicher & Schuell Bioscience, Dassel, Germany). The
membranes were then saturated with 5% skim milk in Tris
Buffered Saline (TBS) containing 0.1% Tween 20 for 1 hour at
RT. They were then incubated with primary antibody diluted at
1/2500 for the anti-CRT C-terminal, 1/500 for the anti–CRT N-
terminal domain and 1/1000 for anti-GAPDH in TBS containing
1% skim milk and 0.1% Tween 20. After 3 rinses in PBS/Tween
20, membranes were incubated 1 h at RT with secondary
antibody (diluted at 1/10000 for anti-rabbit IgG HRP, and 1/
5000 for anti-mouse IgG HRP in the same TBS/Tween 20
skimmed milk solution). After secondary antibody removal, blots
were developed using the enhanced chemi-luminescence (ECL)
detection system (Amersham, Piscataway, USA). Each sample was
analysed in triplicate in three separate experiments.
Quantification of viral protein and CRT expression by
cytofluorimetry
Twenty four hours post infection with recombinant CDV
(rgA75/17-V)-GFP virus, Vero cells were trypsinized and re-
seeded in new plates at 56105 cells. In these series of experiments,
to ascertain cell surface staining, cells were mechanically recovered
in ice cold PBS containing 2 mM EDTA at 12, 24, 36 and
48 hours, respectively and fixed in a BD FACSTM fixation
solution, which preserves plasma membrane integrity (Becton and
Dickinson BD Bioscience, Erembodegem, Belgium). Alternatively,
in figure 1E, cells were recovered in a similar way 36 hours post
infection but treated with the BD FACSTM Perm 2 fixation/
permealization solution (Becton and Dickinson BD Bioscience,
Erembodegem, Belgium). After blocking with PBS containing 1%
goat serum, the cells were stained for one hour at 4uC using
antisera or antibodies specific for F protein or CRT N- and C-
terminal domains, and secondary goat anti-rat and anti-mouse-
Cy5 were added for one hour at 4uC. Cell fluorescence was
monitored by flow cytometry using FACSCaliburTM and FACS-
Diva software (Becton and Dickinson BD Bioscience, Erembode-
gem, Belgium). One representative experiment was shown of three
independent experiments.
Results
CDV infection induces ER stress
We previously demonstrated that CDV infection of rat
hippocampal primary cultures induced neuronal death in a
glutamate-dependent manner [3]. To assess whether this apoptosis
was triggered by a virus-dependent induction of cellular stress, we
first focused on malfunctions at the level of the ER. We took
advantage of a previously described recombinant CDV (rgA75/
17-V, which efficiently infects Vero cells and expresses high
amount of e-GFP) to monitor infection. Importantly, this virus
induces a non-cytolytic, persistent type of infection in many cell
types including Vero cells. Indeed, no obvious signs of cyotpathic
effects are seen up to 6 days post infection and infected cells can
efficiently be passaged several times before cyotpathic effects can
be observed [10]. This recombinant virus rgA75/17-V is referred
to in this study as CDV to simplify the nomenclature. 24 hours
post-infection, we monitored CRT expression as a marker of ER
stress [18,19] by means of immunofluorescence in fixed and
permeabilized Vero cells. In GFP positive infected cells, CRT
staining was strongly enhanced (Figure 1B, middle panel, white
arrow head) as compared to neighbouring non-infected cells or
control culture (Figure 1A and B). Immunostaining of two
additional ER stress markers -the proapoptotic transcription factor
CHOP/GADD 153 [6] and the chaperon protein calnexin [5]-
specifically stained infected cells, confirming the CDV-mediated
ER stress induction (Figure 1C and D, white arrows heads). To
confirm these data in a quantitative manner, increased expression
of all markers (CRT, CHOP/GADD 153, and calnexin) in CDV-
infected cells was monitored by flow cytometry (Figure 1E).
36 hours post-infection, CDV-infected cells (as sorted by GFP
expression) revealed a significant increase of all three ER stress
marker expressions. In a sharp contrast, in non-infected cells of the
same culture (GFP-), ER stress markers did not significantly differ
from isotype control (Figure 1E).
The viral glycoproteins F and H induce ER stress and
alteration in Ca2+ homeostasis
We next investigated whether both CDV surface glycoproteins,
F and H, were sufficient to induce the aforementioned ER stress.
Vero cells were transiently transfected with F or H-expressing
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plasmids and immunofluorescence in fixed and permeabilized
cells was performed 24 hours post-infection (Figure 2Ab and Ac).
As expected, the staining indicated that both proteins were
localized along the secretory pathway up to the plasma
membrane, though cell surface staining in fixed and permeabi-
lized cells remained moderate. However, efficient cell surface
expression of both proteins has already been demonstrated [21–
24]. Importantly, the staining was clearly enhanced around
nuclei, suggesting ER accumulation. Indeed, co-staining of CRT,
as a widely used marker of ER localisation [20], with F or H
clearly indicated their co-localization, confirming the expected F
and H targeting into the endoplasmic reticulum compartment
(Figure 2Ab–c). Hence, similar to results obtained in CDV-
infected cells (Figure 1), Vero cells transiently expressing F and H
exhibited accumulation of both glycoproteins in the ER, a
phenotype that correlated with CRT over-expression (Figure 2Ab
and 2Ac). Conversely, there was no significant CRT upregulation
in non-transfected cells (data not shown), in cells expressing the
cytosolic CDV nucleocapsid protein (N) or in cells expressing an
unrelated glycoprotein (the signaling lymphocytic activation
molecule -SLAM/CD150-), (Figure 2Aa and 2Ad). Together,
these results strongly support the hypothesis that CDV-induced
ER stress is mediated by the accumulation of F and H in the ER
compartment.
Figure 1. Infection of Vero cells by rgA75/17-V (CDV) induces ER stress. (A, B, C, D) Representative photomicrographs of non-infected Vero
cells (A) and infected with a Vero cell-adapted canine distemper virus (CDV) strain (rgA75/17-V). The former recombinant CDV expresses the
enhanced green fluorescence protein (e-GFP) for easier identification of infected cells (B, C, D). Cultures were infected 1 day after seeding. Cells were
then fixed and permeabilized and subsequently analysed by immunofluorescence at 24 hours (A, B and D) or 48 hours (C) after infection. Antibodies
against the protein F of CDV (F), calreticulin, CHOP-GADD and Calnexin are as indicated in the panels. Merged images are shown on bottom panels,
including labelling with 496-diamidino-2-phenylindole (DAPI, blue). Scale bar, 30 mm. Calreticulin and calnexin expression are increased in infected
cells that expressed the F protein (B and D) and at 48 hours post-infection, infected cells also express strongly the nuclear proapoptotic CHOP/GADD
153 (C). (E) Increase of CRT, CHOP/GADD 153 and calnexin during culture infection, as determined by flow cytofluorimetry. Each sample was analysed
in triplicate on three separate experiments, and one representative experiment is shown here.
doi:10.1371/journal.pone.0032803.g001
CDV Glycoproteins Induce Vasostatin Release
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e32803
CDV Glycoproteins Induce Vasostatin Release
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e32803
We previously documented that CDV could induce a significant
release of L-glutamate from hippocampal primary cell cultures.
Interestingly, it has been suggested that following virus-induced
ER-stress, Ca2+ may be released from the ER [25–27]. We thus
investigated whether intracellular Ca2+ is released as a result of
CDV glycoproteins expression. This was achieved by using the
GFP-aequorin reporter assay [16,17]. Figure 2B illustrates that
Ca2+ signals in Vero cells transfected with the nucleocapsid gene
(N) did not show any differences in the recorded signals as
compared to that obtained with the unrelated SLAM/CD150
gene. In contrast, in CDV F-, H- or F/H-expressing cells,
substantial increased Ca2+ signals were recorded, corresponding to
release of Ca2+ in the cytosol (Figure 2B, F, H and F+H). We also
tested cells which expressed an engineered F protein that bears the
GFP fused to its c-terminal domain, allowing for a direct
assessment of F localisation in transfected cells without drastically
impeding F functionality (not shown). This protein triggered a
similar enhancement of Ca2+ cytosolic release (Figure 2B, F-GFP).
Finally, as a positive control of ER-stress induction, we expressed
an F protein which contains an ER-retention tag signal (KDEL)
fused to its cytosolic tail (F-ER) and consequently exclusively
accumulates in the ER (not shown), as anticipated [21]. F-ER did
potently trigger Ca2+ cytosolic release when it was expressed alone
or co-expressed with H (Figure 2B, F-ER and F-ER+H,
respectively).
Hippocampal cultures transfected with CDV
glycoproteins show ER stress and altered Ca2+
homeostasis
To investigate whether the ER stress was also induced by CDV
in a more physiologically relevant model, dissociated cells derived
from rat brain hippocampus were used [12]. Consistent with
results obtained in Vero cells, Figure 3A indicates that F-GFP
(most detection-sensitive mutant) strongly accumulated in the ER.
As we previously observed in Vero cells, accumulation in the ER
of F-GFP correlated with significant enhancement of CRT
expression, in turn reflecting ER stress induction. Similar results
were observed with untagged F or H proteins (not shown).
We next assessed the alteration of Ca2+ homeostasis in primary
rat brain cells. As seen in Figure 3B, cells transfected with empty
vector or N-expressing plasmid did not reveal any enhanced
cytoplasmic Ca2+ release, whereas co-expression of F and H
glycoproteins resulted in a marked increase in cytosolic Ca2+
concentration. These data were further validated by our ER-stress
triggering control (F-ER) that was here co-expressed with H, and
which resulted in even stronger Ca2+ release than in F and H-
expressing cells (Figure 3B). Taken together, our results obtained
in Vero cells were confirmed in primary rat brain cells. Indeed,
expressing both CDV glycoproteins in primary neuronal cells led
to ER-stress induction and ER calcium-depletion.
CRT fragmentation is specifically induced by CDV
infection
CRT is not only used as a marker of ER stress induction (when
upregulated) but is also an important contributor to Ca2+
homeostasis. We thus explored whether the structure and/or
localization was altered in CDV-infected cells. In a first series of
experiments, Western blots were performed in order to analyze
CRT during infection. Two different CRT antibodies were used: a
monoclonal antibody (employed in the previous staining experi-
ments) that recognizes the C-terminal part of the protein, and a
polyclonal antiserum, which is directed against the N-terminal part
of the protein (Figure 4A).
While the full-length CRT protein was detected to similar
extend in infected and non-infected cells, an additional fragment
of about 30 kDa was exclusively observed in CDV-infected cells.
This 30 kDa band was recognized by the C-terminal-specific
antibody (Figure 4B, left blot). The apparent low levels of
cleaved fragments correspond to the fact that only 15% of the
cells were infected at the time of cell lysis, as evaluated by
counting GFP positive cells. We sought to detect the second
putative cleavage product of the full-length CRT, i.e. the N-
terminal region using the N-terminal CRT antiserum. We
detected the full-length CRT protein and a fragment of about
27 kDa, which corresponded to the N-terminal CRT fragment
called vasostatin [28], in addition to several smaller bands (not
shown) (Figure 4B, right blot).
To investigate whether CRT fragmentation is specifically
dependent on CDV infection, we assessed the effect of two drugs:
dithiothreitol (DTT) and thapsigargin (Th). Both drugs are known
to induce ER stress by two different mechanisms: inducing protein
misfolding or blocking ER Ca2+ ATPase pump activity, respec-
tively [29]. In DTT- and Th-treated Vero cells, there was a clear
dose-dependent accumulation of CRT in the ER, compared to
non-treated cells, as revealed by immunofluorescence analysis of
fixed and permeabilized cells (Figure 4C). The highest drug
concentration (4 mM) exhibited the most severe CRT increase.
Higher drug concentrations were clearly cytotoxic (data not
shown). Strikingly, neither DTT nor Th treatment induced
detectable CRT fragmentation (immunoblot Figure 4D lanes 1–
5 and 6–10), whereas in CDV-infected cells, a clear band
migrating with a molecular weight of about 27 kDa was present
(right immunoblot, lane 11). In summary, our cellular and
biochemical data provide strong evidence that CRT fragmenta-
tion is specifically mediated by CDV infection. Because drug-
induced cellular ER stress did not cause any detectable increase of
the CRT cleavage process, our results suggest that virus-induced
ER stress may be different in some way from that induced by DTT
or Th. Alternatively, CRT cleavage in CDV-infected cells might
require additional effects that viral glycoprotein expression would
induce.
Figure 2. CDV F and H surface glycoproteins accumulate in the ER, induce increased CRT expression and cause changes in Ca2+
homeostasis in Vero cells. (A) Vero cells were transiently transfected with plasmids expressing CDV protein N (Aa), F (Ab), H (Ac) or the SLAM/
CD150 construct (Ad). Top row: schematic representation of their respective protein structures. Top panels: immunofluorescence at 24 hours post-
transfection for N, F, H, and SLAM/CD150 (in green). Middle panels: immunofluorescence for CRT (in red). Bottom panels show merged images,
including nuclear staining with DAPI (in blue). The viral F and H glycoproteins accumulated within the ER lumen and co-localize with strongly
expressed CRT (empty white arrow heads). In contrast, cytosolic N CDV protein is not localized to the ER and does not induce CRT upregulation.
(Compare empty white arrow head corresponding to N CDV protein, and white arrow head indicating CRT). SLAM/CD150 does not induce CRT
upregulation. Scale bars, 30 mm. The immunofluorescence assays were performed in fixed and permeabilized cells. (B) Investigation of Ca2+
homeostasis. Vero cells were co-transfected with GFP-aequorin (GA) and different combination of the CDV glycoproteins and SLAM/CD150, as
indicated above each panel. 24 hours after transfection, 5 mM Coelenterazine was added and photon counting started 60 minutes later. At the end
of the experiment 2 mM of ionomycin was added to completely empty ER Ca2+ stores, followed by high Ca2+ solution (10 mM, shown by the last
peak ‘‘High/Ca2+’’ and represented by an asterisk (*). This enabled an estimation of GA expression levels and allows normalization between the
acquisitions.
doi:10.1371/journal.pone.0032803.g002
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CDV-dependent re-localisation of the 27 kDa vasostatin
CRT fragment at the plasma membrane
Cleavage of CRT is known to release the N-terminal fragments,
also known as vasostatin [28]. To determine if the vasostatin is
released from infected cells, Vero cells were infected with CDV for
24 hours, trypsinized and re-plated into new wells for additional
time periods. This was performed to ascertain synchronization of
the putative release of CRT fragments between all infected wells. To
ascertain specific cell surface-exposed CRT staining, immunofluo-
rescence was performed on non-fixed and non-permeabilized cells
at 4uC to prevent internalisation. Quantitative data were recorded
by cytofluorimetry. Infected cells could be distinguished from non-
infected cells by their GFP expression from the recombinant virus.
As a control for surface protein expression, we used an anti-F
antiserum, which demonstrated an increase in mean fluorescence
intensity (MFI) by 12 hours after re-plating, and this, only in
infected cells (Figure 5A; F). We saw no significant enhanced signals
from infected cells using the antibody targeting the CRT C-
terminus (Figure 5A; CRT C-term). In contrast, a substantial
increase was recorded when using the N-terminal antiserum in both
the CDV-inoculated cultures and the non-infected cells, suggesting
secretion of vasostatin and binding to cell surface receptor
(Figure 5A; CRT N-term). Non-infected cultures did not stain with
this antibody, indicating that it was specifically due to the presence
of infected cells. We then investigated by means of immunofluo-
rescence the sub-cellular localisation of CRT fragments in CDV-
infected cells. This was performed in fixed and permeabilized cells.
While CRT staining remained almost exclusively cytosolic using the
C-terminal-recognizing antibody, the N-terminal-recognizing anti-
body illuminated both the cytosol and the plasma membrane.
Furthermore, co-staining of CRT with WGA, a marker for all cell
membranes, revealed that only the N-terminal fragment of the
CRT co-localized with the marker (Figure 5Bf).
In summary, we demonstrated that both CRT antibodies
stained the cytosol but that only the N-terminal-recognizing
antibody stained the plasma membrane. This specific recognition
of the N terminal fragment at the cell surface was confirmed by
cytofluorimetry and immunofluorescence assays. Altogether, this
provides strong evidence that only N-terminal fragments of the
CRT, but not the full-length protein or C-terminal fragments, are
re-localized to the plasma membrane of the infected and
neighbouring non-infected cells. This pattern is consistent with
the N-terminal fragment being the vasostatin, a secreted,
biologically active fragment of CRT.
Discussion
In this study we explored the molecular events associated with
ER stress induced by Morbillivirus infection and transient
expression of viral glycoproteins. CRT is a luminal ER chaperon
implicated in the folding of newly synthesized proteins, a
component of the ER quality control system [9,30,31]. The N-
terminal and the central P domains of CRT display the chaperon
function and can bind the hydrophobic parts of the nascent
proteins in the ER thus preventing protein aggregation [32]. In
addition, by accumulating Ca2+ in its C-terminal domain [14,33],
CRT is the major Ca2+-binding and buffering protein in the ER
lumen [34,35]. During virus infection, viral glycoproteins are
folded and glycosylated in the ER and further processed in the
Golgi apparatus. While the release of Ca2+ from ER stores appears
to be the primary initiator of the ER stress response and cellular
apoptosis [25–27,36–38], the primary mechanism responsible for
the disruption of calcium homeostasis remains unknown. Herein
we report for the first time that accumulation of CDV
Figure 3. CDV F and H surface glycoproteins accumulate in the
ER, induce increased CRT expression and cause changes in Ca2+
homeostasis in primary hippocampal cells. (A) Top panel:
Drawing representing the F-GFP construct. F-GFP was transfected into
primary hippocampal neurons. Bottom panels: visualisation of cells
expressing F (green fluorescence) and CRT (red fluorescence). For CRT
staining, immunofluorescence was performed in fixed and permeabi-
lized cells. The two panels are merged together with DAPI staining in
the very bottom panel. As in Vero cells, this chimera induced an
increased CRT expression. Scale bars, 30 mm. (B) Investigation of Ca2+
homeostasis. Primary hippocampal neurons were co-transfected with
empty vector and the CDV protein-expressing vectors as indicated in
the top panel. Below, the graphs exhibit combined curves of Ca2+
release in the cytosol upon expression of the indicated proteins. The
bottom graph is a magnification of the middle graph, which is a
magnification of the top graph. All samples were analysed in triplicate
on three separate experiments, and one representative experiment is
shown here. The recorded Ca2+ responses are consistent with the ER F
and H protein accumulation and subsequent ER stress observed in Vero
cells.
doi:10.1371/journal.pone.0032803.g003
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Figure 4. CDV infection of Vero cells causes CRT fragmentation with vasostatin formation. (A) Schematic representation of the 60 kDa
CRT protein. The globular 27 kDa N-terminal domain (N-term) is the most important antigenic site of the protein. This domain, as well as the P
domain, possesses the chaperon function. C-terminal domain (C-term) is important for Ca2+ storage and possesses the KDEL ER retention signal. P
and C-terminal domains have together an estimated mass of 30 kDa. (B) The Vero cells were either left non-infected or infected with CDV. At 48 h
post-infection cells were lysed and analyzed by Western blot using C-terminal-specific (left) or N-terminal-specific (right) antibodies. Note the C-
terminal 30 kDa fragment, and the 27 kDa N-terminal fragment. GAPDH is used as an internal control. (C) Impact of the ER stress inducing drugs
dithiothreitol (DTT) and thapsigargin (Th) on CRT expression during CDV infection. Red fluorescence in all panels corresponds to CRT
immunostaining, which increases in a DTT concentration-dependent manner (top panels) or in a thapsigargin concentration-dependent manner
(white arrow heads). For comparison, calreticulin staining is shown in infected cells probed by immunostaining of the F protein (bottom left and
insert panels). Immunofluorescence analyses were performed in fixed and permeabilized cells. (D) Western blot using the antibody recognizing either
the N- terminal domain of CRT (27 kDa, right panel) or the C- terminal domain (30 kDa; left panel). Both antibodies recognize the full-length CRT (top
line, 60 kDa). Cellular extracts come from Vero cells exposed to DTT or thapsigargin (Th), or CDV infected as indicated. GAPDH was used as an internal
control. CRT cleavage was specifically mediated by CDV infection (line 11) and not by exposure to DTT or thapsigargin.
doi:10.1371/journal.pone.0032803.g004
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glycoproteins in the ER, CRT over-expression and ER stress
correlated very well with the disruption of ER Ca2+ homeostasis of
infected cells. Importantly, our results obtained in Vero cells were
recapitulated in primary rat hippocampal culture. Furthermore,
we showed that CDV could induce CRT fragmentation and
selective secretion of the CRT N-terminal fragment, also known as
vasostatin, and its binding to cell surface to both infected cells and
neighbouring non-infected cells.
Depletion of Ca2+ from ER stores, an event potentially triggered
by ER stress, critically affects the survival of CNS cells by inducing
Figure 5. CRT N-terminal fragments are re-localized at the cell surface. (A) The kinetics of the appearance of the F protein and CRT C-
terminal and N-terminal fragments at the surface of infected Vero cells were monitored by flow cytofluorimetry using the corresponding specific
antibodies. Control cell cultures were not infected (grey lines). From infected cell cultures, infected cells (red line; GFP-positive) and non-infected cells
(blue line, GFP-negative) were identified by virus-encoded GFP fluorescence. Cell surface immuno-labelling of cells (unifxed and nonpermeablized)
with F and CRT C-terminal and N-terminal were performed with specific antibodies as indicated at the top of the panels. The mean fluorescence
intensity (MFI) of the labelling was determined within each cell population regularly over 48 hours of infection (top panels). The three bottom panels
represent the distribution of the MFI within each population at 48 hours post-infection. Here is shown one representative experiment out of three
independent experiments. (B) Membrane localisation of CRT N-terminal fragment following CDV infection. At 24 hours post-infection in Vero cells,
cultures were immuno-labelled for the viral F protein to identify infected cells (Ba; fluorochrome: FITC), C-terminal specific anti-CRT antibody (Bb;
fluorochrome: CY3), and N-terminal specific anti-CRT antibody (Bc; fluorochrome: CY5). In panel Bd, cell membranes were stained with alexa-405-
conjugated wheat germ agglutinin (WGA). The merges images b and d (Be) reveal little co-localisation of CRT C-terminal fragment with the cell
surface, while the merges images c and d (Bf) indicate partial surface localization of the CRT N-terminal fragment. Panel g is a merge between images
b and c. Scale bar, 30 mm. Immunofluorescence analyses were performed in fixed and permeabilized cells.
doi:10.1371/journal.pone.0032803.g005
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proapoptotic stimuli and the exocytotic release of synaptic vesicles
[39–41]. These events could explain the apoptotic death of CNS-
infected cells [42] as well as apoptosis of neighbouring non-
infected brain cells as a result of Ca2+-induced L-glutamate release
[3]. In the CNS, both neurons and glial cells can be infected by
CDV in dogs and other carnivores [1]. In the early stage of
infection, CDV causes an acute infection followed by a subacute
stage leading in some cases to chronic infection. During acute
infection, demyelination has been described as being a direct
consequence of virus replication, in the absence of detectable
inflammation [1]. In contrast, during chronic demyelination,
plaque progression seems to be mainly related to an immuno-
pathological process [43]. Based on these and our past [3] and
present observations, we suggest that in the acute phase of the
infection in the CNS, neurodegenerative events are at least in part
initiated by an ER stress, which increases CRT expression and
perturbs Ca2+ homeostasis, subsequently releasing L-glutamate
[3]. Altered Ca2+ homeostasis and L-glutamate release in turn
cause rapid CNS degeneration (within days or a week)
corresponding to the acute phase of the disease. The fact that
we observed this cascade of molecular events in the immune
deficient Vero cells does not exclude that in vivo some more
primordial defence system of the infected cells contribute to the
initiation of the neurodegenerescence.
Under physiological conditions, full-length CRT [35] or N-
terminal fragments [44] have been detected in small amounts at
the cell surface. Importantly, the adaptive immune system is
strongly activated by increasing amounts of full-length CRT
[45,46] or by vasostatin, the 27 kDa N-terminal CRT fragment
[28] at the cell surface. Here, we reported that CDV can also
trigger CRT fragmentation and relocation of the N-terminal
vasostatin CRT fragment to the cell surface of both infected and
non-infected cells (Figure 6). Though CRT cleavage appeared to
be caused by CDV-induced ER stress, the fact that the well-known
ER stress inducers thapsigargin and DTT do not cause CRT
cleavage, suggest that the triggering of ER stress may not be
equivalent in both conditions. Interestingly, cell surface localiza-
tion or secretion of the vasostatin has been first described in
Epstein-Barr-Virus (EBV)-infected cells [44,47] although the
precise molecular mechanism underlying this phenomenon
remains undetermined. Pike and co-workers additionally demon-
strated that vasostatin efficiently inhibited endothelial cell
proliferation and could supressed angiogenesis in vivo [28]. In
addition, vasostatin also significantly reduced tumor growth in
mice [47]. While one possible explanation to explain CDV-
induced CRT cleavage would implicate a direct role of F and/or
Figure 6. Mechanistic model of neurodegenerative processes
induced by CDV infection. The F and H CDV proteins are
accumulating in the ER. This event induces an early ER stress event.
In early ER stress, the quantities of CRT chaperon increase, the Ca2+
homeostasis is altered and Ca2+ is depleted from ER stores. Increase of
cytosolic Ca2+ can have as consequence a glutamate release during CDV
infection as previously described [3]. Glutamate release could induce, in
the neighbouring neurons, Ca2+ entry followed by an ER stress
induction [56]. During ER stress, the infected cells show enhance
expression of the chaperons CRT, calnexin and GRP94 and relocalisation
of the transcription factor ATF-6 in the nucleus followed by the
expression of the proapoptotic factor CHOP/GADD 153. More
importantly, infected cells show CRT fragmentation in a CDV-
dependent manner. C-terminal fragments are retained in the ER by
the KDEL signal whereas CRT N-terminal fragments are present after
24 hours at the cell surface. Cell surface exposition of CRT N-terminal
fragment may contribute to CDV-mediated neurodegenerative auto-
immunity. In grey italic are events described in previous publications.
doi:10.1371/journal.pone.0032803.g006
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H on CRT processing and subsequent secretion of the vasostatin
from the cell, any other indirect effects cannot be rule out. Further
works are hence warranted to illuminate the precise molecular
mechanism leading to CRT cleavage in CDV-infected cells.
Moreover, we speculate that secretion of the CDV-induced N-
terminal vasostatin fragment may contribute to the establishment
of the chronic phase of the disease over many months or years.
Indeed, vasostatin may stimulate the adaptive immune system,
which may generate auto-antibodies directed against it. This
alteration might even be amplified by the fact that we detected the
vasostatin on the surface of non-infected cells in infected cultures,
suggestive of a molecular mechanism by which the released CRT
fragments might bind to an unknown receptor on the surface of
neighbouring cells [44,46] (Figure 6). Increased CRT-specific
auto-antibodies have been reported in autoimmune diseases such
as Sjo¨grens’s syndrome and systemic lupus erythematosus. In some
cases these diseases show neurodegenerative progression
[44,48,49]. It is interesting to note that early stages of multiple
sclerosis and systemic lupus erythematosus share some clinical
signs than those induced by CDV [50]. Alternatively, vasostatin-
dependent inhibition of angiogenesis in the brain may also
contribute to CDV-induced neurological disorders.
Additional effects of CRT cell surface exposure are known in
cancer progression and therapies. Indeed, in mouse models,
exposure of CRT on a tumour cell surface following treatment
with chemotherapeutic agents caused apoptosis, tumour immu-
nogenicity and cancer cell death [45]. Consistent with these
finding, CDV and MV infections showed promising oncolytic
activity in a mouse model of lymphoma carcinomas [51]. The
MV-mediated anti-tumour response has been characterized as an
immune response triggering cell apoptosis in hepatocellular
carcinoma and human cutaneous T cell lymphoma [52–54].
The fact that MV infection in human lymphoma induces ER-
resident stress proteins [55] is in line with our own observations
linking viral infection-mediated ER stress and CRT exposed at the
cell surface. While the molecular mechanisms of oncolytic action
mediated by CDV and MV very likely are governed by F/H-
induced syncytium formation and subsequent cell lysis, they are
not yet completely elucidated. Thus, it is tempting to speculate that
vasostatin on the cell surface of both infected and neighbouring
cells may contribute to anti-tumour activity in vivo.
In conclusion, we demonstrate that during morbillivirus
infection the accumulation of viral surface glycoproteins in the
ER induces an ER stress characterized by Ca2+ release, apoptosis
and CRT fragmentation. The N-terminal fragment of CRT,
vasostatin, is secreted and binds to the cell surface of both infected
cells and neighbouring cells. An auto-antibodies response to
vasostatin, as described in other disease, might result in
neurodegenerative-autoimmunity.
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